[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100643160":3},{"organization":4,"armGroups":7,"interventions":28,"overallOfficials":46,"centralContacts":51,"locations":33,"responsibleParty":57,"collaborators":33,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":33,"eligibilityCriteria":67,"healthyVolunteers":68,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":33,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":33,"overallStatus":81,"whyStopped":33,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":33},{"fullName":5,"class":6},"Nishtar Medical University","OTHER",[8,14,19,23],{"label":9,"type":10,"description":11,"interventionNames":12},"TEST TOOTHPASTE GROUP 1","EXPERIMENTAL","Participants in this arm will use the test toothpaste twice daily for 8 weeks.",[13],"Other: TOOTH PASTE(NHA)",{"label":15,"type":16,"description":11,"interventionNames":17},"TEST TOOTH PASTE GROUP 2","ACTIVE_COMPARATOR",[18],"Other: TOOTH PASTE (NOVAMIN)",{"label":20,"type":16,"description":11,"interventionNames":21},"TEST TOOTH PASTE GROUP 3",[22],"Other: TOOTH PASTE (PROARGIN)",{"label":24,"type":25,"description":11,"interventionNames":26},"TEST TOOTH PASTE GROUP 4","PLACEBO_COMPARATOR",[27],"Other: TOOTH PASTE ( NON DESENSITIZING)",[29,34,38,42],{"type":6,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"TOOTH PASTE(NHA)","TOOTH PASTES CONTAINING NHA.",[9],null,{"type":6,"name":35,"description":36,"armGroupLabels":37,"otherNames":33},"TOOTH PASTE (NOVAMIN)","TOOTH PASTE CONTAINING NOVAMIN",[15],{"type":6,"name":39,"description":40,"armGroupLabels":41,"otherNames":33},"TOOTH PASTE (PROARGIN)","TOOTH PASTE CONTAINING PROARGIN.",[20],{"type":6,"name":43,"description":44,"armGroupLabels":45,"otherNames":33},"TOOTH PASTE ( NON DESENSITIZING)","TOOTH PASTE A NON-DESENSITIZING CONTROL",[24],[47],{"name":48,"affiliation":49,"role":50},"Dr. Zubair Hassan Awaisi, FCPS","PRINCIPAL NID MULTAN","STUDY_CHAIR",[52],{"name":53,"role":54,"phone":55,"phoneExt":33,"email":56},"FATIMA KHALID, BDS","CONTACT","03128287657","fatimakhalid9921@gmail.com",{"type":58,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":33,"oldOrganization":33},"PRINCIPAL_INVESTIGATOR","Fatima Khalid","Dr Fatima Khalid","100643160","dentin-hypersensitivity-in-orthodontic-patients-triple-blinded-randomized-trial-of-three-desensitizing-agents-100643160",false,"NCT07641322","Dentin Hypersensitivity in Orthodontic Patients: Triple-Blinded, Randomized Trial of Three Desensitizing Agents.","Dentin Hypersensitivity: Triple-Blinded, Multicenter Randomized Trial of Three Desensitizing Dentifrices vs Non-Desensitizing Control","Inclusion Criteria:\n\n* Orthodontic patients aged 18-40 years.\n* Presence of mild to moderate dentin hypersensitivity (VAS ≥ 4).\n* Willingness to comply with a 12-week follow-up period.\n* No active periodontal disease or untreated caries.\n* Not pregnant or breastfeeding.\n* No history of allergy to desensitizing agents\n\nExclusion Criteria:\n\n* o Patients with systemic conditions affecting oral health (e.g., diabetes, immunocompromised).\n\n  * Patients using medications that affect tooth sensitivity (e.g., anti-inflammatory drugs).",true,"ALL","18 Years","40 Years",{"count":73,"type":74},200,"ESTIMATED","INTERVENTIONAL",[77],"NA","The effect of desensitizing agents will be studied on dentin hypersensitivity in orthodontic patients.it is a randomized controlled trial. three experimental groups and one placebo group.",[80],"Dentin Desensitizing Agents","NOT_YET_RECRUITING","2026-06-07",{"date":84,"type":85},"2026-06-11","ACTUAL",{"date":87,"type":74},"2026-07-15",{"date":89,"type":74},"2026-12-15",{"name":5,"class":6}]